AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1672803 — intervention group
Group type: EXPERIMENTAL
Intervention: atracurium 0.6 mg.kg‐1
Number of subjects: 30
Study 1672803 — intervention group
Group type: EXPERIMENTAL
Intervention: vecuronium 0.1 mg.kg‐1
Number of subjects: 30
Study 1672803 — intervention group
Group type: EXPERIMENTAL
Intervention: half‐dose combinations of atracurium and vecuronium
Number of subjects: 30
Study 1672803 — intervention group
Group type: EXPERIMENTAL
Intervention: quarter‐dose combinations of atracurium and vecuronium
Number of subjects: 30
Study 1672803 — intervention group
Group type: EXPERIMENTAL
Intervention: full‐dose combinations of atracurium and vecuronium
Number of subjects: 30
Study 7043395 — intervention group
Group type: EXPERIMENTAL
Intervention: Piribedil (0.1 mg/kg over 30 minutes)
Number of subjects: 40
Study 7043395 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (prior administration)
Number of subjects: 40
Study 7043395 — intervention group
Group type: COMPARATOR
Intervention: Control group (subjects free from headache)
Number of subjects: 40
Study 30281094 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT)
Number of subjects: 14
Study 30281094 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 14
Study 27887967 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-guided percutaneous nerve cryoablation
Number of subjects: 21
Study 27716691 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 mcg/kg IV over 20 min followed by 0.5 mcg/kg/h for 72 h postoperative
Number of subjects: 90
Study 27716691 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone 5 mg/kg IV over 20 min followed by 10-15 mcg/kg/h for 72 h postoperative
Number of subjects: 90
Study 27716691 — intervention group
Group type: COMPARATOR
Intervention: Normal saline IV
Number of subjects: 90
Study 24760465 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound scissors
Number of subjects: 41
Study 24760465 — intervention group
Group type: COMPARATOR
Intervention: Monopolar electrosurgery
Number of subjects: 41
Study 21997455 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive training program (30 minutes, 3 times a week for 6 weeks) including 5 exercises with the BOSU and Swiss ball.
Number of subjects: 33
Study 21997455 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 33
Study 19229114 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic yogurt (300 g/day for 6 weeks)
Number of subjects: 14
Study 19229114 — intervention group
Group type: COMPARATOR
Intervention: Ordinary yogurt (300 g/day for 6 weeks)
Number of subjects: 14
Study 17218125 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid collars (TCs) during radiography
Number of subjects: 200
Study 17218125 — intervention group
Group type: COMPARATOR
Intervention: No thyroid collars (non-TC group)
Number of subjects: 200
Study 15359221 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Imagery with Progressive Muscle Relaxation (GI with PMR)
Number of subjects: 28
Study 15359221 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study 11261907 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.3 mg/kg and 2% lignocaine infiltration
Number of subjects: 50
Study 11261907 — intervention group
Group type: COMPARATOR
Intervention: Ketamine 0.9 mg/kg and diazepam 0.07 mg/kg
Number of subjects: 50
Study 9651414 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (CI)
Number of subjects: 92
Study 9651414 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacologic-only intervention (PO)
Number of subjects: 92
Study 9651414 — intervention group
Group type: COMPARATOR
Intervention: Cross-sectional control group
Number of subjects: 92
Study 7735519 — intervention group
Group type: EXPERIMENTAL
Intervention: Olea europaea pollen extract (immunotherapy)
Number of subjects: 15
Study 7735519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 1684178 — intervention group
Group type: EXPERIMENTAL
Intervention: Broxaterol patch (size = 1.75 cm2; programmed delivery = 105 mcg/h)
Number of subjects: 10
Study 1684178 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 10
Study 6819891 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) with constant infusion of hypertonic glucose and amino acids by central vein (35 kcal/kg/day)
Number of subjects: 50
Study 6819891 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 50
Study 6819891 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 50
Study 29189585 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated-sprint running with deceleration (TMd)
Number of subjects: 14
Study 29189585 — intervention group
Group type: COMPARATOR
Intervention: Repeated-sprint running without deceleration (TMa)
Number of subjects: 14
Study 30230658 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch‐up for Toddlers (ABC‐T)
Number of subjects: 88
Study 30230658 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 88
Study 28654155 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D (CaD) supplementation
Number of subjects: 34763
Study 28654155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34763
Study 25723973 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention with breastfeeding support
Number of subjects: 36
Study 25723973 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention without breastfeeding support
Number of subjects: 36
Study 25723973 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (dietary intervention issued at three months postpartum)
Number of subjects: 36
Study 23863050 — intervention group
Group type: EXPERIMENTAL
Intervention: Radium-223 (50 kBq/kg IV, six injections every 4 weeks)
Number of subjects: 921
Study 23863050 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching injections every 4 weeks)
Number of subjects: 921
Study 22101697 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinfeng capsule (XFC), 3 capsules, thrice a day for 30 days (2 courses)
Number of subjects: 68
Study 22101697 — intervention group
Group type: COMPARATOR
Intervention: Fengshi gutong capsule (FSGTC), 4 capsules, twice a day for 30 days (2 courses)
Number of subjects: 68
Study 22101697 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinfeng capsule (XFC)
Number of subjects: 68
Study 19346990 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (self-reported using Active Australia questionnaire)
Number of subjects: 120
Study 19346990 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36 physical component summary scores
Number of subjects: 120
Study 19346990 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36 physical functioning measures
Number of subjects: 120
Study 17588706 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 87
Study 17588706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 15361940 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (GM) at 1 mg/kg/hour for 5 days or longer
Number of subjects: 50
Study 15361940 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated with GM)
Number of subjects: 50
Study 11738121 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral treatments
Number of subjects: 0
Study 11738121 — intervention group
Group type: COMPARATOR
Intervention: Change of HIV‐1 RNA at the end of follow‐up
Number of subjects: 0
Study 11738121 — intervention group
Group type: COMPARATOR
Intervention: HIV‐1 RNA area‐under‐the‐curve during follow‐up minus baseline
Number of subjects: 0
Study 9673806 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT) as an adjunct treatment
Number of subjects: 11
Study 9673806 — intervention group
Group type: COMPARATOR
Intervention: Relaxation Training/Thermal Biofeedback (RTB)
Number of subjects: 11
Study 9673806 — intervention group
Group type: COMPARATOR
Intervention: Physical Therapy (PT) alone
Number of subjects: 11
Study 7991725 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 89
Study 7991725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 3149884 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical mupirocin (3 daily applications for 8 days)
Number of subjects: 62
Study 3149884 — intervention group
Group type: COMPARATOR
Intervention: Oral erythromycin ethylsuccinate (40 mg/kg/day divided into four doses for 8 days)
Number of subjects: 62
Study 30779821 — intervention group
Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone (DBB)
Number of subjects: 17
Study 30779821 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical mineralized allogeneic bone (MAB)
Number of subjects: 17
Study 30779821 — intervention group
Group type: COMPARATOR
Intervention: Comparison between DBB and MAB
Number of subjects: 17
Study 28604251 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian diet (V)
Number of subjects: 74
Study 28604251 — intervention group
Group type: COMPARATOR
Intervention: Conventional anti-diabetic diet (C)
Number of subjects: 74
Study 28604251 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 74
Study 25515106 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I) - single 60-70 minute session with self-help pamphlet (n = 20)
Number of subjects: 40
Study 25515106 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group (n = 20)
Number of subjects: 40
Study 25623312 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectin (24 g/d for 4 weeks)
Number of subjects: 80
Study 25623312 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 80
Study 20842375 — intervention group
Group type: EXPERIMENTAL
Intervention: ActiGraph prediction models
Number of subjects: 277
Study 20842375 — intervention group
Group type: EXPERIMENTAL
Intervention: Actical models
Number of subjects: 277
Study 20842375 — intervention group
Group type: EXPERIMENTAL
Intervention: RT3 proprietary models
Number of subjects: 277
Study 20842375 — intervention group
Group type: EXPERIMENTAL
Intervention: All prediction models for ADLs
Number of subjects: 277
Study 20842375 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven equations for TRD activities
Number of subjects: 277
Study 20842375 — intervention group
Group type: EXPERIMENTAL
Intervention: Four equations for TRD activities
Number of subjects: 277
Study 20842375 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction equations overall
Number of subjects: 277
Study 18358071 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/day SDG
Number of subjects: 87
Study 18358071 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/day SDG
Number of subjects: 87
Study 18358071 — intervention group
Group type: COMPARATOR
Intervention: 0 mg/day SDG (placebo)
Number of subjects: 87
Study 17302251 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted low-dose indinavir (200 mg twice daily) and lamivudine (150 mg twice daily)
Number of subjects: 26
Study 17302251 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted low-dose indinavir and lamivudine
Number of subjects: 26
Study 12957192 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfuvirtide (90 mg twice daily) at injection site: abdomen
Number of subjects: 12
Study 12957192 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfuvirtide (90 mg twice daily) at injection site: thigh
Number of subjects: 12
Study 12957192 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfuvirtide (90 mg twice daily) at injection site: arm
Number of subjects: 12
Study 12957192 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfuvirtide (90 mg twice daily)
Number of subjects: 12
Study 10711924 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidectomy
Number of subjects: 22
Study 10711924 — intervention group
Group type: COMPARATOR
Intervention: Conventional haemorrhoidectomy
Number of subjects: 22
Study 9437183 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (4 g daily equivalent to 0.91 g n‐3 VLCPUFA)
Number of subjects: 47
Study 9437183 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil (placebo)
Number of subjects: 47
Study 1312078 — intervention group
Group type: EXPERIMENTAL
Intervention: WR‐2721 and radiation
Number of subjects: 100
Study 1312078 — intervention group
Group type: COMPARATOR
Intervention: Radiation only
Number of subjects: 100
Study 4036847 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg cholesterol daily
Number of subjects: 19
Study 4036847 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg cholesterol daily
Number of subjects: 19
Study 4036847 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg cholesterol daily
Number of subjects: 19
Study 4036847 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg cholesterol daily (healthy women)
Number of subjects: 19
Study 4036847 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg cholesterol daily (healthy women)
Number of subjects: 19
Study 31935197 — intervention group
Group type: EXPERIMENTAL
Intervention: Siponimod
Number of subjects: 36
Study 31935197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 29773827 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine
Number of subjects: 19
Study 29773827 — intervention group
Group type: COMPARATOR
Intervention: metoprolol
Number of subjects: 19
Study 29773827 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study 26707946 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Case Conceptualisation (CCC)
Number of subjects: 32
Study 26707946 — intervention group
Group type: COMPARATOR
Intervention: Standardised assessment condition (assessment as usual; AAU)
Number of subjects: 32
Study 24392774 — intervention group
Group type: EXPERIMENTAL
Intervention: WUP 3 ([(AT-LT)/2] above AT)
Number of subjects: 11
Study 24392774 — intervention group
Group type: COMPARATOR
Intervention: WUP 1 ([(AT-LT)/2] below LT)
Number of subjects: 11
Study 24392774 — intervention group
Group type: COMPARATOR
Intervention: WUP 2 (midway between LT and AT)
Number of subjects: 11
Study 24392774 — intervention group
Group type: COMPARATOR
Intervention: No WUP
Number of subjects: 11
Study 22772929 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed learners (minimal, mild, severe depression)
Number of subjects: 222
Study 22772929 — intervention group
Group type: COMPARATOR
Intervention: Non-depressed learners
Number of subjects: 222
Study 22772929 — intervention group
Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 222
Study 22772929 — intervention group
Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 222
Study 20977087 — intervention group
Group type: EXPERIMENTAL
Intervention: RMK (0.25% ropivacaine, morphine 0.2 mg/mL, ketorolac 1 mg/mL)
Number of subjects: 26
Study 20977087 — intervention group
Group type: EXPERIMENTAL
Intervention: RMK
Number of subjects: 26
Study 20977087 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 26
Study 17662749 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue
Number of subjects: 151
Study 17662749 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 151
Study 17662749 — intervention group
Group type: COMPARATOR
Intervention: Physical functioning and work status
Number of subjects: 151
Study 16049118 — intervention group
Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation
Number of subjects: 43
Study 16049118 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 43
Study 12358160 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (400 mg) - Test formulation
Number of subjects: 24
Study 12358160 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine (400 mg) - Reference formulation
Number of subjects: 24
Study 10427482 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic levonorgestrel (LNG) 100 micrograms/ethinylestradiol (EE) 20 micrograms
Number of subjects: 384
Study 7488279 — intervention group
Group type: EXPERIMENTAL
Intervention: CAMPATH‐1H (1, 3, 10, 30, 60, and 100 mg)
Number of subjects: 40
Study 7488279 — intervention group
Group type: EXPERIMENTAL
Intervention: CAMPATH‐1H
Number of subjects: 40
Study 2297656 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-hour continuous infusion of doxorubicin
Number of subjects: 62
Study 2297656 — intervention group
Group type: COMPARATOR
Intervention: Standard rapid infusion of doxorubicin (15 to 20 minutes)
Number of subjects: 62
Study 2297656 — intervention group
Group type: COMPARATOR
Intervention: Standard rapid infusion of doxorubicin
Number of subjects: 62
Study 7348120 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentazocine (1 mg/kg)
Number of subjects: 0
Study 7348120 — intervention group
Group type: COMPARATOR
Intervention: Nalorphine (5 mg)
Number of subjects: 0
Study 7348120 — intervention group
Group type: COMPARATOR
Intervention: Naloxone (0.4 mg)
Number of subjects: 0
Study 7348120 — intervention group
Group type: COMPARATOR
Intervention: No opiate antagonists
Number of subjects: 0
Study 31856666 — intervention group
Group type: EXPERIMENTAL
Intervention: RNAknot
Number of subjects: 131
Study 31856666 — intervention group
Group type: COMPARATOR
Intervention: Vs_subopt, CyloFold, IPknot, Kinefold, RNAstructure, Sfold
Number of subjects: 131
Study 28110255 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patients in psychiatric cases
Number of subjects: 0
Study 28110255 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 25865087 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined diabetes specialist/mental health team approach
Number of subjects: 58
Study 25865087 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 58
Study 23708746 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin generic formulations (three generic formulations)
Number of subjects: 24
Study 23708746 — intervention group
Group type: COMPARATOR
Intervention: Branded formulation of gabapentin
Number of subjects: 24
Study 21062906 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modifications (dietary restriction and exercise)
Number of subjects: 57000000
Study 21062906 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 57000000
Study 21062906 — intervention group
Group type: EXPERIMENTAL
Intervention: Certain medications
Number of subjects: 57000000
Study 19463392 — intervention group
Group type: EXPERIMENTAL
Intervention: Myoblast transplantation using the Biosense‐NOGA 3‐dimensional‐guided endomyocardial delivery system
Number of subjects: 23
Study 19463392 — intervention group
Group type: COMPARATOR
Intervention: Control group (no myoblast transplantation)
Number of subjects: 23
Study 19463392 — intervention group
Group type: EXPERIMENTAL
Intervention: Myoblast transplantation
Number of subjects: 23
Study 19463392 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study 17244243 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 unit/ml of heparin saline
Number of subjects: 123
Study 17244243 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 units/ml of heparin saline
Number of subjects: 123
Study 17244243 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 123
Study 15062883 — intervention group
Group type: EXPERIMENTAL
Intervention: African Americans
Number of subjects: 2727
Study 15062883 — intervention group
Group type: COMPARATOR
Intervention: Whites
Number of subjects: 2727
Study 12647460 — intervention group
Group type: EXPERIMENTAL
Intervention: Day hospital treatment for acute psychiatric patients
Number of subjects: 0
Study 12647460 — intervention group
Group type: COMPARATOR
Intervention: Conventional inpatient hospital care
Number of subjects: 0
Study 9640147 — intervention group
Group type: EXPERIMENTAL
Intervention: von Langenbeck palatoplasty
Number of subjects: 312
Study 9640147 — intervention group
Group type: EXPERIMENTAL
Intervention: push‐back palatoplasty
Number of subjects: 312
Study 9640147 — intervention group
Group type: EXPERIMENTAL
Intervention: combined push‐back palatoplasty and superior pharyngeal flap surgery
Number of subjects: 312
Study 8605897 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1 g/day
Number of subjects: 222
Study 8605897 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone 2 g/day
Number of subjects: 222
Study 2665059 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin treatment (25 U fast-acting insulin bolus followed by continuous infusion of 1 U/kg b.w. for 1 hour)
Number of subjects: 17
Study 2665059 — intervention group
Group type: COMPARATOR
Intervention: Control group (no insulin treatment)
Number of subjects: 17
Study 793766 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidulated phosphate fluoride (APF 1.23%)
Number of subjects: 1653
Study 793766 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1653
Study 31078180 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter edge‐to‐edge repair (MitraClip)
Number of subjects: 0
Study 28898239 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling for Alcohol Problems (CAP) plus enhanced usual care (EUC)
Number of subjects: 377
Study 28898239 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC) alone
Number of subjects: 377
Study 25562591 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-rated CGI-S
Number of subjects: 1010
Study 25562591 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-rated CGI-S
Number of subjects: 1010
Study 23709323 — intervention group
Group type: EXPERIMENTAL
Intervention: Crushed MSN (≥60/2.4 mg)
Number of subjects: 14
Study 23709323 — intervention group
Group type: COMPARATOR
Intervention: Intact MSN
Number of subjects: 14
Study 21733166 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive urodynamic testing (IUT)
Number of subjects: 0
Study 21733166 — intervention group
Group type: COMPARATOR
Intervention: Basic clinical assessment with non-invasive tests
Number of subjects: 0
Study 21733166 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative interviews of women
Number of subjects: 0
Study 21733166 — intervention group
Group type: EXPERIMENTAL
Intervention: National survey of clinicians
Number of subjects: 0